Calcipotriol: Difference between revisions

From Proteopedia
Jump to navigationJump to search
No edit summary
No edit summary
Line 6: Line 6:
In mouse studies, topical calcipotriol administration to the ear and dorsal skin led to a dose-dependent increase in the production of the epithelial cell-derived cytokine TSLP by keratinocytes, and triggered atopic dermatitis at high concentrations.<ref name="a10">PMID:16880407</ref> This upregulation of TSLP production due to calcipotriol application is thought to be mediated through the coactivation of [[vitamin D receptor]]/[[Retinoid X receptor]] α and [[vitamin D receptor]]/[[Retinoid X receptor]] β heterodimers.
In mouse studies, topical calcipotriol administration to the ear and dorsal skin led to a dose-dependent increase in the production of the epithelial cell-derived cytokine TSLP by keratinocytes, and triggered atopic dermatitis at high concentrations.<ref name="a10">PMID:16880407</ref> This upregulation of TSLP production due to calcipotriol application is thought to be mediated through the coactivation of [[vitamin D receptor]]/[[Retinoid X receptor]] α and [[vitamin D receptor]]/[[Retinoid X receptor]] β heterodimers.
   
   
[[1s19]].
<scene name='10/1023614/Cv/2'>VDR ligand binding domain complexed to calcipotriol</scene> ([[1s19]]).
</StructureSection>
</StructureSection>
== References ==
== References ==
<references/>
<references/>

Revision as of 13:21, 22 January 2024

Caption for this structure

Drag the structure with the mouse to rotate

References

Proteopedia Page Contributors and Editors (what is this?)

Alexander Berchansky